Rallybio (RLYB) Insider Trading & Ownership $0.30 +0.01 (+4.39%) Closing price 03:58 PM EasternExtended Trading$0.32 +0.01 (+4.24%) As of 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Rallybio (NASDAQ:RLYB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.70%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$26,050.00Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$4.00 M Get RLYB Insider Trade Alerts Want to know when executives and insiders are buying or selling Rallybio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RLYB Insider Buying and Selling by Quarter Rallybio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/14/2023Jonathan I LieberInsiderBuy5,000$5.21$26,050.00 3/7/2023Kush ParmarDirectorSell100,000$8.20$820,000.00 6/3/2022Kush ParmarDirectorSell150,000$12.50$1,875,000.00 5/23/2022Kush ParmarDirectorSell100,000$13.00$1,300,000.00 (Data available from 1/1/2013 forward) RLYB Insider Trading Activity - Frequently Asked Questions Who is on Rallybio's Insider Roster? The list of insiders at Rallybio includes Jonathan I Lieber, and Kush Parmar. Learn more on insiders at RLYB. What percentage of Rallybio stock is owned by insiders? 8.70% of Rallybio stock is owned by insiders. Learn more on RLYB's insider holdings. Rallybio Key ExecutivesDr. Martin W. MacKay Ph.D. (Age 68)Co-Founder & Executive Chairman Compensation: $723.35kDr. Stephen Uden M.B (Age 66)M.D., Co-Founder, President, CEO & Director Compensation: $723.35kMr. Jonathan I. Lieber M.B.A. (Age 54)CFO & Treasurer Compensation: $667.13kDr. Steven W. Ryder F.A.C.P (Age 72)M.D., Chief Medical Officer Compensation: $680.22k More Insider Trading Tools from MarketBeat Related Companies VRCA Insider Transactions XLO Insider Transactions MRSN Insider Transactions SPRO Insider Transactions TNYA Insider Transactions OKYO Insider Transactions ANEB Insider Transactions AADI Insider Transactions APLT Insider Transactions BLUE Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold This page (NASDAQ:RLYB) was last updated on 4/29/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rallybio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rallybio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
